FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3131726382> ?p ?o ?g. }

• W3131726382 endingPage "284" @default.
• W3131726382 startingPage "284" @default.
• W3131726382 abstract "Malignant melanoma is one of the most deadly types of solid cancers, a property mainly attributed to its highly aggressive metastatic form. On the other hand, different classes of isothiocyanates, a class of phytochemicals, present in cruciferous vegetables have been characterized by considerable anti-cancer activity in both in vitro and in vivo experimental models. In the current study, we investigated the anti-cancer response of five isothiocyanates in an in vitro model of melanoma consisting of non-metastatic (A375, B16F-10) and metastatic (VMM1, Hs294T) malignant melanoma as well as non-melanoma epidermoid carcinoma (A431) and non-tumorigenic melanocyte-neighboring keratinocyte (HaCaT) cells. Our aim was to compare different endpoints of cytotoxicity (e.g., reactive oxygen species, intracellular glutathione content, cell cycle growth arrest, apoptosis and necrosis) descriptive of an anti-cancer response between non-metastatic and metastatic melanoma as well as non-melanoma epidermoid carcinoma and non-tumorigenic cells. Our results showed that exposure to isothiocyanates induced an increase in intracellular reactive oxygen species and glutathione contents between non-metastatic and metastatic melanoma cells. The distribution of cell cycle phases followed a similar pattern in a manner where non-metastatic and metastatic melanoma cells appeared to be growth arrested at the G2/M phase while elevated levels of metastatic melanoma cells were shown to be at sub G1 phase, an indicator of necrotic cell death. Finally, metastatic melanoma cells were more sensitive apoptosis and/or necrosis as higher levels were observed compared to non-melanoma epidermoid carcinoma and non-tumorigenic cells. In general, non-melanoma epidermoid carcinoma and non-tumorigenic cells were more resistant under any experimental exposure condition. Overall, our study provides further evidence for the potential development of isothiocyanates as promising anti-cancer agents against non-metastatic and metastatic melanoma cells, a property specific for these cells and not shared by non-melanoma epidermoid carcinoma or non-tumorigenic melanocyte cells." @default.
• W3131726382 created "2021-03-01" @default.
• W3131726382 creator A5002900771 @default.
• W3131726382 creator A5009015359 @default.
• W3131726382 creator A5022987454 @default.
• W3131726382 creator A5045502541 @default.
• W3131726382 creator A5053337281 @default.
• W3131726382 creator A5058307008 @default.
• W3131726382 creator A5059314345 @default.
• W3131726382 creator A5091249150 @default.
• W3131726382 date "2021-02-13" @default.
• W3131726382 modified "2023-10-01" @default.
• W3131726382 title "An Evaluation of the Anti-Carcinogenic Response of Major Isothiocyanates in Non-Metastatic and Metastatic Melanoma Cells" @default.
• W3131726382 cites W1529951251 @default.
• W3131726382 cites W1590527279 @default.
• W3131726382 cites W1825557015 @default.
• W3131726382 cites W1892194484 @default.
• W3131726382 cites W1982344941 @default.
• W3131726382 cites W1990632141 @default.
• W3131726382 cites W2002273856 @default.
• W3131726382 cites W2028286877 @default.
• W3131726382 cites W2035503754 @default.
• W3131726382 cites W2037022356 @default.
• W3131726382 cites W2042322942 @default.
• W3131726382 cites W2045658350 @default.
• W3131726382 cites W2050067759 @default.
• W3131726382 cites W2051704735 @default.
• W3131726382 cites W2054408892 @default.
• W3131726382 cites W2058890723 @default.
• W3131726382 cites W2064173767 @default.
• W3131726382 cites W2077248954 @default.
• W3131726382 cites W2078019756 @default.
• W3131726382 cites W2078553155 @default.
• W3131726382 cites W2084282937 @default.
• W3131726382 cites W2084451406 @default.
• W3131726382 cites W2095200952 @default.
• W3131726382 cites W2096151075 @default.
• W3131726382 cites W2101875154 @default.
• W3131726382 cites W2104695873 @default.
• W3131726382 cites W2106237569 @default.
• W3131726382 cites W2134291954 @default.
• W3131726382 cites W2134421488 @default.
• W3131726382 cites W2138018577 @default.
• W3131726382 cites W2142669820 @default.
• W3131726382 cites W2144147936 @default.
• W3131726382 cites W2158799429 @default.
• W3131726382 cites W2162537441 @default.
• W3131726382 cites W2299413166 @default.
• W3131726382 cites W2329072498 @default.
• W3131726382 cites W2465569291 @default.
• W3131726382 cites W2515813844 @default.
• W3131726382 cites W2519235371 @default.
• W3131726382 cites W2548080267 @default.
• W3131726382 cites W2555133689 @default.
• W3131726382 cites W2565812783 @default.
• W3131726382 cites W2585359117 @default.
• W3131726382 cites W2589266856 @default.
• W3131726382 cites W2616823333 @default.
• W3131726382 cites W2735913246 @default.
• W3131726382 cites W2768103628 @default.
• W3131726382 cites W2790466173 @default.
• W3131726382 cites W2805876262 @default.
• W3131726382 cites W2807965241 @default.
• W3131726382 cites W2905212065 @default.
• W3131726382 cites W2905385734 @default.
• W3131726382 cites W2912819439 @default.
• W3131726382 cites W2937883230 @default.
• W3131726382 cites W2946240897 @default.
• W3131726382 cites W2946812414 @default.
• W3131726382 cites W2959062040 @default.
• W3131726382 cites W2992786191 @default.
• W3131726382 cites W3013565617 @default.
• W3131726382 cites W3082460377 @default.
• W3131726382 cites W3086889166 @default.
• W3131726382 cites W3089181147 @default.
• W3131726382 doi "https://doi.org/10.3390/antiox10020284" @default.
• W3131726382 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7918923" @default.
• W3131726382 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33668498" @default.
• W3131726382 hasPublicationYear "2021" @default.
• W3131726382 type Work @default.
• W3131726382 sameAs 3131726382 @default.
• W3131726382 citedByCount "6" @default.
• W3131726382 countsByYear W31317263822021 @default.
• W3131726382 countsByYear W31317263822022 @default.
• W3131726382 countsByYear W31317263822023 @default.
• W3131726382 crossrefType "journal-article" @default.
• W3131726382 hasAuthorship W3131726382A5002900771 @default.
• W3131726382 hasAuthorship W3131726382A5009015359 @default.
• W3131726382 hasAuthorship W3131726382A5022987454 @default.
• W3131726382 hasAuthorship W3131726382A5045502541 @default.
• W3131726382 hasAuthorship W3131726382A5053337281 @default.
• W3131726382 hasAuthorship W3131726382A5058307008 @default.
• W3131726382 hasAuthorship W3131726382A5059314345 @default.
• W3131726382 hasAuthorship W3131726382A5091249150 @default.
• W3131726382 hasBestOaLocation W31317263821 @default.
• W3131726382 hasConcept C118995209 @default.
• W3131726382 hasConcept C121608353 @default.
• W3131726382 hasConcept C126322002 @default.

• next